China A-share indices mixed; innovative drug stocks surge, Hong Kong indexes fall over 1%
On September 17, China’s A-share market closed with mixed results: the Shanghai Composite fell 0.21%, while the Shenzhen Component rose 0.37%, the ChiNext gained 0.77%, and the STAR Market rose 0.45%. Pharmaceuticals and biotechnology led gains, with innovative drug stock Jinshi Ya Yao hitting a 20% daily limit up. In contrast, Hong Kong’s Hang Seng Index and Hang Seng Tech Index both fell more than 1%.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page reads the event directly, while its address stays stable when the title changes.
- Summary covers the current reports
Cross-source coverage
Reporting timeline
Shanghai Composite Rises 1.04%; Semiconductor and AI Chip Stocks Lead Market Surge
In the morning session on September 18, China's A-share markets saw broad gains, with the Shanghai Composite Index closing up 1.04%, the Shenzhen Component Index up 1.52%, and the ChiNext Index surging 2.11%. The semiconductor industry chain led the rally, with sectors including memory chips, AI chips, and advanced packaging posting strong gains. Multiple stocks, such as Torrance, Chengbang Shares, Huatian Technology, and Broadcom Integrated, hit their daily price limits. Computing power concept stocks also rose steadily, with Zhongdian Xinlong and Dongyi Risheng hitting daily limits. The retail and innovative drug sectors advanced as well. On the downside, whole-vehicle manufacturing, glass and fiberglass, coal, shipping and ports, fisheries, and crop cultivation sectors declined. Half-day trading volume across the Shanghai and Shenzhen markets totaled approximately 1.32 trillion yuan, an increase of about 74.3 billion yuan compared to the same period yesterday. Approximately 4,300 stocks rose market-wide, while 800 declined.
Read sourceChina A-Share Markets Mixed; ChiNext Rises, Drug Stocks Surge, Hong Kong Falls
On September 17, China's A-share markets showed mixed performance. The Shanghai Composite Index fell 0.21%, while the Shenzhen Component Index rose 0.37%, the ChiNext Index gained 0.77%, and the STAR Market Composite Index increased 0.45%. Sector-wise, pharmaceuticals and biotechnology, fiberglass, and cultural media led the gains, while precious metals, oil and gas, and natural gas sectors experienced volatile adjustments. The article highlights that innovative drug concept stocks showed active performance, with Jinshi Ya Yao (stock code 300434) hitting a 20% daily limit up. In contrast, Hong Kong stock markets declined, with both the Hang Seng Index and the Hang Seng Tech Index falling by more than 1%. The report is attributed to China Fund News reporter Li Zhi.
Read sourceA-Share Market Mixed; ChiNext Rises Over 1%, Hong Kong Stocks Fall
On September 17, China's A-share market showed mixed performance. The Shanghai Composite Index fell 0.21%, while the Shenzhen Component Index rose 0.37%, the ChiNext Index gained 0.77%, and the STAR Market Composite Index increased 0.45%. Sector-wise, pharmaceuticals and biotechnology, fiberglass, and cultural media led the gains, while precious metals, oil and gas, and natural gas experienced volatile adjustments. The article, published by Sohu Finance and written by China Fund News reporter Li Zhi, also notes that innovative drug concept stocks showed active performance, with Jinshi Ya Yao hitting a 20% daily limit up. Meanwhile, Hong Kong stock markets declined, with both the Hang Seng Index and the Hang Seng Tech Index falling by more than 1%.
Read sourceShow 7 older updatesHide older updates
China A-Share Market Mixed; Innovative Drug Stocks Surge, Hong Kong Indexes Fall
On September 17, China's A-share market showed mixed performance. The Shanghai Composite Index fell 0.21%, while the Shenzhen Component Index rose 0.37%, the ChiNext Index gained 0.77%, and the STAR Market Composite Index increased 0.45%. Sector-wise, pharmaceuticals and biotechnology, fiberglass, and cultural media led the gains, while precious metals, oil and gas, and natural gas experienced volatile adjustments. Notably, innovative drug concept stocks performed actively, with Jinshi Ya Yao (stock code 300434) hitting a 20% daily limit up. In contrast, Hong Kong stock markets declined, with both the Hang Seng Index and the Hang Seng Tech Index falling by more than 1%. The report is by Li Zhi of China Fund News.
Read sourceA-share indices mixed; innovative drug stocks surge with Jinshi Ya Yao hitting 20% limit
On September 17, China's A-share markets showed mixed performance. The Shanghai Composite Index fell 0.21%, while the Shenzhen Component Index rose 0.37%, the ChiNext Index gained 0.77%, and the STAR Market Composite Index increased 0.45%. Sector-wise, pharmaceuticals and biotechnology, fiberglass, and cultural media led gains, while precious metals, oil and gas, and natural gas experienced volatile adjustments. Innovative drug concept stocks showed active performance, with Jinshi Ya Yao hitting a 20% daily limit up. In Hong Kong, both the Hang Seng Index and the Hang Seng Tech Index fell by more than 1%, continuing a decline. The report was authored by Li Zhi of China Fund News.
Read sourceA-Share Indices Mixed; ChiNext Rises Over 1% as Pharma and Biotech Lead Gains
On September 17, China's A-share markets showed mixed performance. The Shanghai Composite Index fell 0.21%, while the Shenzhen Component Index rose 0.37%, the ChiNext Index gained 0.77%, and the STAR Market Composite Index increased 0.45%. Sector-wise, pharmaceuticals and biotechnology, fiberglass, and cultural media led the gains, whereas precious metals, oil and gas, and natural gas experienced volatile adjustments. The article, reported by China Fund News' Li Zhi, also notes that the Hong Kong stock market declined, with both the Hang Seng Index and the Hang Seng Tech Index falling by more than 1%. The lead-in highlights active performance in innovative drug concept stocks, specifically mentioning Jinshi Ya Yao hitting a 20% daily limit up.
Read sourceA-Share Market Mixed; Innovative Drug Stocks Surge, Jinshi Ya Yao Hits Limit
On September 17, China's A-share market closed with mixed results. The Shanghai Composite Index fell 0.21%, while the Shenzhen Component Index rose 0.37%, the ChiNext Index gained 0.77%, and the STAR Market Composite Index increased by 0.45%. Sector performance varied, with pharmaceuticals and biotechnology, fiberglass, and cultural media leading gains, while precious metals, oil and gas, and natural gas experienced volatile adjustments. Notably, innovative drug concept stocks showed active performance, with Jinshi Ya Yao hitting a 20% daily limit up. In contrast, Hong Kong stock markets declined, with both the Hang Seng Index and the Hang Seng Tech Index falling more than 1%. The report, authored by Li Zhi of China Fund News and published on Sohu Finance, provides a snapshot of the day's trading activity.
Read sourceA-Share Markets Mixed; Innovative Drug Stocks Surge as Jinshi Ya Yao Hits 20% Limit Up
On September 17, China's A-share markets showed mixed performance, with the Shanghai Composite Index falling 0.21%, while the Shenzhen Component Index rose 0.37%, the ChiNext Index gained 0.77%, and the STAR Market Composite Index increased 0.45%. The pharmaceuticals and biotechnology sector led gains, with innovative drug concept stocks performing actively, notably Jinshi Ya Yao hitting a 20% daily limit up. Other gaining sectors included fiberglass and cultural media, while precious metals, oil and gas, and natural gas sectors experienced volatile adjustments. Meanwhile, Hong Kong stock markets declined, with both the Hang Seng Index and Hang Seng Tech Index falling by more than 1%. The report is attributed to China Fund News reporter Li Zhi.
Read sourceA-Share Markets Mixed; Innovative Drug Stock Jinshi Ya Yao Hits 20% Daily Limit
On September 17, China's A-share markets showed mixed performance. The Shanghai Composite Index fell 0.21%, while the Shenzhen Component Index rose 0.37%, the ChiNext Index gained 0.77%, and the STAR Market Composite Index increased 0.45%. Sector-wise, pharmaceuticals and biotechnology, fiberglass, and cultural media led the gains, while precious metals, oil and gas, and natural gas sectors experienced volatile adjustments. Notably, innovative drug concept stocks were active, with Jinshi Ya Yao hitting a 20% daily limit up. In contrast, Hong Kong stock markets declined again, with both the Hang Seng Index and the Hang Seng Tech Index falling by more than 1%. The report is attributed to China Fund News reporter Li Zhi.
Read sourceA-share indices mixed; innovative drug stocks surge, Jinshi Ya Yao hits limit
On September 17, China's A-share market showed mixed performance across major indices. The Shanghai Composite Index fell 0.21%, while the Shenzhen Component Index rose 0.37%, the ChiNext Index gained 0.77%, and the STAR Market Composite Index increased 0.45%. Sector-wise, pharmaceuticals and biotechnology, fiberglass, and cultural media led the gains, while precious metals, oil and gas, and natural gas experienced volatile adjustments. Notably, innovative drug concept stocks showed active performance, with Jinshi Ya Yao hitting a 20% daily limit up. In contrast, the Hong Kong stock market declined, with both the Hang Seng Index and the Hang Seng Tech Index falling by more than 1%. The report is attributed to China Fund News reporter Li Zhi.
Read source